REDWOOD SHORES, Calif., Nov. 7 /PRNewswire-FirstCall/ -- Organizations spanning the life sciences industry -- including biotechnology firms, contract research organizations, as well as pharmaceutical and medical device manufacturers -- are choosing applications, infrastructure software and services from Oracle to help them accelerate and optimize new product development cycle time, enhance operational efficiency, improve sales and marketing effectiveness, streamline regulatory compliance and reduce risk.
(Logo: http://www.newscom.com/cgi-bin/prnh/20020718/ORCLLOGO )
Today, 20 of the top 20 pharmaceutical companies and 10 of the top 10 medical device companies run Oracle(R) Applications. Similarly, 28 of the top 30 pharmaceutical companies run Oracle infrastructure software and 18 of the top 20 medical device companies run Oracle infrastructure software. Organizations selecting applications, infrastructure software and/or services from Oracle include: Albany Molecular Research, Inc.; Amarin Corporation plc; Bayer Consumer Care; Beijing Pharmaceutical Group Co., Ltd.; Ceva Sante Animale; Edwards Lifesciences LLC; (OSI) Eyetech; Hyundai Pharmaceutical; Medi-Flex, Inc.; LEO Pharma S/A; Recigno Laboratories Inc.; Regeneron Pharmaceuticals, Inc.; Smiths Medical; Napp Pharmaceuticals; and STERIS Corporation.
Organizations in the life sciences industry must juggle a set of increasingly complex challenges. With the average cost of new drug development creeping toward $1 billion, life sciences organizations face unprecedented pressure to accelerate development and testing, while improving operational efficiencies and optimizing sales and marketing initiatives. At the same time, these organizations must comply with an increasingly complex web of national and international regulations that require the compilation and management of vast quantities of information from multiple sources.
"To help life sciences organizations thrive in today's complex environment, Oracle delivers the market-leading information platform and most complete and integrated application suite for life sciences -- from innovation through patient contact," said Oracle Vice President for Health Industries Mychelle Mowry. "This integrated continuum allows life sciences organizations -- from biotech start-ups to international manufacturers -- to achieve new levels of innovation, minimize risk and maximize profitability in bringing new drugs, medical equipment and devices to market."
Smiths Medical Streamlines Global Business Processes
Smiths Medical, a U.K-based leading international provider of medical devices for hospitals, emergency rooms, home care and specialist environments, is deploying a single global instance of the Oracle E-Business Suite intended to streamline more than 120 of the organization's global processes. Smiths is replacing disparate legacy applications with a single information technology (IT) platform capable of operating across multiple therapy areas and legal entities. The implementation consisting of 35 modules including Oracle Order Management, Oracle Inventory Optimization and Oracle Advanced Supply Chain Planning, will support an integrated, transparent global supply chain designed to help Smiths enhance operational efficiency, increase customer satisfaction and reduce costs.
With the Oracle E-Business Suite, Smiths looks to improve supply chain performance; enable automatic, rules-based stock replenishment from the most suitable location using global inventory views; and enhance decision making and customer service with more accurate and timely data.
LEO Pharma A/S Reduces Time to Market with Oracle Clinical Applications
Denmark-based LEO Pharma A/S, a leading provider of dermatological and thromboembolic disorders treatments, implemented Oracle Clinical and Oracle Remote Data Capture applications to accelerate recording and validation of clinical trial participant data, helping the organization to reduce time to market for its products. Oracle Remote Data Capture helped LEO Pharma improve efficiency and reduce costs by eliminating manual transcription of all trial data from patient case records to a paper-based patient case report form (CRF).
For decades, paper has been the primary mechanism for collecting clinical trial data. However, paper-based systems lead to errors and inefficiencies. As clinical data volumes rise by 20 percent annually, collecting trial data on paper is no longer a viable option. Oracle Clinical Remote Data Capture provides an efficient, scalable electronic data capture system that emulates paper-based methods using Adobe Portable Document Format.
With Oracle Remote Data Capture, LEO Pharma reduced the processing time from last patient visit to database lock from six to 12 weeks to one to two weeks, reducing the cost of patient monitoring and improving the productivity of clinical trial patient visits. The implementation also facilitated faster real-time data collection and evaluations.
"Oracle Remote Data Capture's convenient user interface has been well received by our Clinical Research Associates and employees at research sites. Remote Data Capture is stable, works well and has good support from Oracle," said LEO Pharma A/S Head of Corporate Clinical Data and Document Management Alastair Clewlow.
Ceva Sante Animale Streamlines Operations and Facilitates Regulatory Compliance
Ceva Sante Animale, a veterinary pharmaceutical laboratory covering all aspects of animal health, deployed Oracle's JD Edwards EnterpriseOne to facilitate compliance with regulatory requirements around supply chain traceability and create a centralized system for managing financial and manufacturing operations.
"With JD Edwards EnterpriseOne, we can respond to powerful regulatory and traceability constraints and keep in step with the group's growth via centralized management of logistics and item codes," said Ceva Sante Animale Information Systems Director Vincent Brillot.
STERIS Corporation Maps Path Forward
STERIS Corporation -- a leading provider of infection prevention, decontamination and health science technologies, products and services -- recently looked to Oracle's Insight Program to help it create a solution priority map to determine IT priorities essential to helping the organization advance its business strategy. Working with Oracle, STERIS -- based in Mentor, Ohio -- created a list of priorities, built internal consensus around IT projects, including the rollout of Oracle's manufacturing applications, and mapped a phased implementation plan and roadmap to execute against.
"In the true spirit of partnership, Oracle brought together strategy, industry expertise, as well as operational and tactical professionals with the Oracle Insight program to help identify business opportunities. I see this as an investment in the future of our long-term relationship," said STERIS Corporation Chief Information Officer Sanjay Lall.
About Oracle
Oracle is the world's largest enterprise software company. For more information about Oracle, visit our Web site at http://www.oracle.com/.
Trademarks
Oracle, JD Edwards, PeopleSoft, and Siebel are registered trademarks of Oracle Corporation and/or its affiliates. Other names may be trademarks of their respective owners.
AP Archive: http://photoarchive.ap.org/
PRN Photo Desk,
© 2006 PR Newswire
